documents: FDA-2017-N-1129-0048
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-N-1129-0048 | FDA | FDA-2017-N-1129 | Attachment 2 Beger et al Metabolomics enables precision medicine: "A White Paper, Community Perspective" Metabolomics (20 16) I 2:149 re: Comment from Bruker | Supporting & Related Material | Background Material | 2017-05-16T04:00:00Z | 2017 | 5 | 2017-05-16T18:35:46Z | 0 | 0 | 09000064825c9a37 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref